share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Alvarez Ralph

SEC announcement ·  Jun 18 16:21
Summary by Moomoo AI
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase of common stock on June 17, 2024. The transaction involved the acquisition of 13 shares at a price of $885.01 per share. Following this transaction, Alvarez directly holds a total of 54,138 shares in the company. The transaction, which is classified as a grant, award, or other acquisition, reflects a continued investment in the company by Alvarez and is indicative of his direct ownership stake in Eli Lilly.
Ralph Alvarez, associated with Eli Lilly and Co (LLY), completed a purchase of common stock on June 17, 2024. The transaction involved the acquisition of 13 shares at a price of $885.01 per share. Following this transaction, Alvarez directly holds a total of 54,138 shares in the company. The transaction, which is classified as a grant, award, or other acquisition, reflects a continued investment in the company by Alvarez and is indicative of his direct ownership stake in Eli Lilly.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more